Structures by: Zieliński W.
Total: 24
5,6-dimethylbenzimidazole phase alpha
C9H10N2
CrystEngComm (2015) 17, 29 5468
a=6.4776(7)Å b=27.51(3)Å c=14.0381(15)Å
α=90° β=102.456(10)° γ=90°
5,6-dimethylbenzimidazole phase alpha
0.5(C18H20N4)
CrystEngComm (2015) 17, 29 5468
a=6.5122(6)Å b=27.61(2)Å c=14.0669(13)Å
α=90° β=102.550(9)° γ=90°
5,6-dimethylbenzimidazole phase beta
0.33(C9H10N2),0.33(C18H19N4)
CrystEngComm (2015) 17, 29 5468
a=6.538(3)Å b=26.99(14)Å c=13.930(5)Å
α=90° β=102.68(4)° γ=90°
5,6-dimethylbenzimidazole phase beta
0.33(C27H30N6)
CrystEngComm (2015) 17, 29 5468
a=6.5011(10)Å b=27.23(2)Å c=13.949(2)Å
α=90° β=102.615(15)° γ=90°
Xcalibur
0.25(H4O4),2(C9H10N2)
CrystEngComm (2015) 17, 29 5468
a=7.5684(10)Å b=12.432(2)Å c=34.803(4)Å
α=90° β=90° γ=90°
5,6-dimethylbenzimidazole hemihydrate
0.25(H4O4),2(C9H10N2)
CrystEngComm (2015) 17, 29 5468
a=7.2661(15)Å b=12.407(8)Å c=34.550(5)Å
α=90° β=90° γ=90°
5,6-dimethylbenzimidazole hemihydrate
0.5(C36H42N8O2)
CrystEngComm (2015) 17, 29 5468
a=7.173(3)Å b=12.383(5)Å c=34.439(4)Å
α=90° β=90° γ=90°
5,6-dimethylbenzimidazole hemihydrate
0.25(H4O4),2(C9H10N2)
CrystEngComm (2015) 17, 29 5468
a=7.040(2)Å b=12.334(4)Å c=34.323(3)Å
α=90° β=90° γ=90°
5,6-dimethylbenzimidazole hemihydrate
0.25(H4O4),2(C9H10N2)
CrystEngComm (2015) 17, 29 5468
a=6.9376(16)Å b=12.228(3)Å c=34.174(2)Å
α=90° β=90° γ=90°
3,5-Diphenyl-1,2,4-triazin-6(1<i>H</i>)-one
C15H11N3O
Acta Crystallographica Section C (2012) 68, 4 o149-o151
a=22.975(5)Å b=5.5835(10)Å c=21.550(5)Å
α=90.00° β=116.06(3)° γ=90.00°
1-[(1-Ethoxypropylidene)amino]-2-ethyl-4-(4-hydroxybenzyl)imidazol- 5(4<i>H</i>)-one
C17H23N3O3
Acta Crystallographica Section C (2012) 68, 3 o141-o143
a=7.9622(2)Å b=14.3492(4)Å c=14.6469(4)Å
α=90.00° β=97.210(2)° γ=90.00°
Benzimidazole phase αlpha
C7H6N2
Crystal Growth & Design (2013) 13, 2 696
a=13.402(2)Å b=6.798(3)Å c=6.9428(7)Å
α=90.00° β=90.00° γ=90.00°
Benzimidazole phase αlpha
C7H6N2
Crystal Growth & Design (2013) 13, 2 696
a=13.189(8)Å b=6.7596(11)Å c=6.9528(14)Å
α=90.00° β=90.00° γ=90.00°
Benzimidazole phase αlpha
C7H6N2
Crystal Growth & Design (2013) 13, 2 696
a=13.098(15)Å b=6.765(8)Å c=6.963(9)Å
α=90.00° β=90.00° γ=90.00°
Benzimidazole phase βetha
C7H6N2
Crystal Growth & Design (2013) 13, 2 696
a=9.6053(16)Å b=16.021(3)Å c=7.4386(14)Å
α=90.00° β=90.00° γ=90.00°
Benzimidazole phase βetha
C7H6N2
Crystal Growth & Design (2013) 13, 2 696
a=9.550(3)Å b=15.840(15)Å c=7.367(4)Å
α=90.00° β=90.00° γ=90.00°
Benzimidazole phase βetha
C7H6N2
Crystal Growth & Design (2013) 13, 2 696
a=9.4896(15)Å b=15.564(3)Å c=7.2671(14)Å
α=90.00° β=90.00° γ=90.00°
Benzimidazole phase βetha
C7H6N2
Crystal Growth & Design (2013) 13, 2 696
a=9.4697(15)Å b=15.511(3)Å c=7.2413(14)Å
α=90.00° β=90.00° γ=90.00°
Benzimidazole phase βetha
C7H6N2
Crystal Growth & Design (2013) 13, 2 696
a=9.4365(16)Å b=15.444(3)Å c=7.2004(15)Å
α=90.00° β=90.00° γ=90.00°
Benzimidazole phase γamma
C7H6N2
Crystal Growth & Design (2013) 13, 2 696
a=9.810(7)Å b=7.966(5)Å c=13.074(9)Å
α=90.00° β=90.00° γ=90.00°
Benzimidazole phase γamma
C7H6N2
Crystal Growth & Design (2013) 13, 2 696
a=9.821(6)Å b=7.969(5)Å c=13.109(9)Å
α=90.00° β=90.00° γ=90.00°
Benzimidazole phase γamma
C7H6N2
Crystal Growth & Design (2013) 13, 2 696
a=9.782(6)Å b=7.859(4)Å c=12.967(8)Å
α=90.00° β=90.00° γ=90.00°
5,6-dimethylbenzimidazole phase beta
0.33(C27H30N6)
CrystEngComm (2015) 17, 29 5468
a=6.487(2)Å b=26.63(12)Å c=13.831(4)Å
α=90° β=102.50(3)° γ=90°
Benzimidazole phase βetha
C7H6N2
Crystal Growth & Design (2013) 13, 2 696
a=9.5230(17)Å b=15.651(3)Å c=7.3106(15)Å
α=90.00° β=90.00° γ=90.00°